Plasma pTau217/Aβ 42 and pTau217 outperform pTau181/Aβ 42 and pTau181 in predicting cerebrospinal fluid amyloid positivity: A real-world retrospective study
Journal of Alzheimer’s Disease · 2025
DOI: 10.1177/13872877251390897 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, 2025. Verfasst von Daniele Imperiale und 20 weiteren Autor:innen. Beteiligte Einrichtung: SC Neurologia, Ospedale Maria Vittoria, Torino, Italy. Hauptthemen laut MEDLINE: Amyloid beta-Peptides, tau Proteins, Peptide Fragments, Alzheimer Disease. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
Background
Alzheimer's disease (AD) diagnosis often relies on invasive cerebrospinal fluid (CSF) sampling or expensive cerebral positron emission tomography (PET) imaging. Noninvasive tests could facilitate early detection. Plasma phosphorylated-tau (pTau) isoforms are promising AD biomarkers that correlate with brain amyloid-β (Aβ) deposition.
Objective
To explore the diagnostic accuracy of pTau-based plasma biomarkers to forecast CSF amyloid-positive status in a real-world consecutive population of subjects with cognitive impairment and complete plasma and CSF biomarker profiles.
Methods
We retrospectively studied 138 consecutive patients with cognitive impairment. Plasma biomarkers (pTau217, pTau181, Aβ 42 , Aβ 40 ) were measured by automated immunoassay. Diagnostic accuracy for CSF amyloid status was assessed using area-under-the curve (AUC) values from receiver-operating characteristic (ROC) curve analysis. A dual-threshold strategy was used to define low- and high-risk groups and estimate how many lumbar punctures could be avoided.
Results
Among 138 patients (37% CSF amyloid-positive), pTau217/Aβ 42 ratio had the highest AUC (0.920) for predicting amyloid positivity, followed by pTau217 (AUC 0.904). These values exceeded the accuracy of pTau181-based markers. Using dual cut-offs, a 90% sensitivity-90% specificity strategy could avoid about 93.5% of lumbar punctures using pTau217/Aβ 42 (10.9% misclassified), and 84.1% when using pTau217 (11.2% misclassified). Stricter thresholds (95%–95% and 97.5%–97.5%) further reduced misclassification rates but at the expense of fewer avoidable invasive procedures.
Conclusions
Plasma pTau217 (alone or combined with Aβ 42 ) shows high accuracy for detecting AD pathology and could serve as a scalable, noninvasive diagnostic tool. This approach may triage patients for confirmatory testing and substantially reduce the need for invasive CSF examination.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- SC Neurologia, Ospedale Maria Vittoria, Torino, Italy.
- Centro regionale Diagnosi Osservazione Malattie Prioniche - Laboratorio di Neurobiologia, Ospedale Maria Vittoria, Torino, Italy.
- SCDU Malattie Infettive, Dipartimento di Scienze Mediche - Università di Torino, Ospedale Amedeo di Savoia, Torino, Italy.
- SC Neurologia, A.O. S. Croce e Carle, Cuneo, Italy.
- SC Neurologia, Nuovo Ospedale degli Infermi, Ponderano, Italy.
- SC Neurologia, Ospedale San Giacomo, Novi Ligure, Italy.
ORCID-Profile: Daniele Imperiale, Mario Coletti Moja, Marco De Mattei
Zitieren
APA
Imperiale, D., Marcinnò, A., Atzori, C., Angeloro, D. P., Murgioni, A., Bagatin, A., Secci, V., Calcagno, A., Capobianco, M. A., Coletti Moja, M., Rota, E., Rosso, M., Bongioanni, M. R., Godi, L., Barra, M., De Mattei, M., Bonzanino, M., Ferrandi, D., Rainero, I., …, & Bozzali, M. (2025). Plasma pTau217/Aβ 42 and pTau217 outperform pTau181/Aβ 42 and pTau181 in predicting cerebrospinal fluid amyloid positivity: A real-world retrospective study. Journal of Alzheimer’s Disease. https://doi.org/10.1177/13872877251390897
Vancouver
Imperiale D, Marcinnò A, Atzori C, Angeloro DP, Murgioni A, Bagatin A, et al. Plasma pTau217/Aβ 42 and pTau217 outperform pTau181/Aβ 42 and pTau181 in predicting cerebrospinal fluid amyloid positivity: A real-world retrospective study. Journal of Alzheimer’s Disease. 2025. doi:10.1177/13872877251390897
BibTeX
@article{Imperiale2025,
author = {Imperiale, Daniele and Marcinnò, Andrea and Atzori, Cristiana and Angeloro, Daniele Pio and Murgioni, Amelia and Bagatin, Alessia and Secci, Valentina and Calcagno, Andrea and Capobianco, Marco Alfonso and Coletti Moja, Mario and Rota, Eugenia and Rosso, Mara and Bongioanni, Maria Roberta and Godi, Laura and Barra, Massimo and De Mattei, Marco and Bonzanino, Massimo and Ferrandi, Delfina and Rainero, Innocenzo and Lopiano, Leonardo and Bozzali, Marco},
title = {Plasma pTau217/Aβ 42 and pTau217 outperform pTau181/Aβ 42 and pTau181 in predicting cerebrospinal fluid amyloid positivity: A real-world retrospective study},
journal = {Journal of Alzheimer’s Disease},
year = {2025},
doi = {10.1177/13872877251390897}
}
EUVIMED